Gala­pa­gos finds Pol­ish part­ner for in­flam­ma­tion drugs; Zai Lab's Ze­ju­la app gets speedy re­view in Chi­na

→ Bel­gium’s Gala­pa­gos and Pol­ish biotech Ryvu are part­ner­ing on a dis­cov­ery and de­vel­op­ment pact for in­flam­ma­tion drugs. Ryvu will …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.